Zicai Liang

Kyushu University — Japan

Biochemistry, Genetics and Molecular Biology · Life Sciences

50h-index8.0kcitations153works0.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

RNA Interference and Gene Delivery(85), Advanced biosensing and bioanalysis techniques(68), MicroRNA in disease regulation(30), Microbial Inactivation Methods(24), Microfluidic and Bio-sensing Technologies(17)

Publications153 total

Store-operated Ca2+ entry mediated by STIM1 and STIM2 regulates salivary secretion and KCa channels in salivary gland
Biochemical and Biophysical Research Communications·2025Open Access
Heredity and gene fine mapping of a small spikelet and compact glume 1 (sscg1) mutant in wheat
Gene·2025
Impaired store-operated Ca <sup>2+</sup> entry in mouse epidermis leads to reduced epidermal barrier function via Klk activation
2025Open Access
A potent GalNAc-siRNA drug, RBD1016, leads to sustained HBsAg reduction and seroconversion in mouse models of HBV infection
Molecular Therapy — Nucleic Acids·2025· 2 citedOpen Access
Author Correction: Osteoclast-derived exosomal miR-214-3p inhibits osteoblastic bone formation
Nature Communications·2025· 1 citedOpen Access
Inhibition of Factor XI Using RBD4059
JACC Basic to Translational Science·2025· 2 citedOpen Access
Effects of Multicultural Disaster Prevention Education Methods in Japan
International Symposium on Affective Science and Engineering·2025Open Access
Publisher Correction to: ISIS 449884 Injection Add‑On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double‑Blind, Placebo‑Controlled, Phase II Clinical Study
Diabetes Therapy·2024Open Access
The efficacy and safety of <scp>ISIS</scp> 449884 injection as monotherapy in patients with type 2 diabetes: A randomized phase <scp>II</scp> study
Diabetes Obesity and Metabolism·2024Open Access
ISIS 449884 Injection Add-On to Metformin in Patients with Type 2 Diabetes: A Randomized, Double-Blind, Placebo-Controlled, Phase II Clinical Study
Diabetes Therapy·2024· 1 citedOpen Access
RBD1016-a novel anti-HBV GalNAc-siRNA drug resulted in sustained HBsAg reduction and seroconversion in mice models
Journal of Hepatology·2023· 4 cited
Effects of HSD17B13-targeting siRNA-R0737072 on Liver Fibrosis and Steatosis in a mouse model of NASH
Journal of Hepatology·2023
Safety and antiviral activity of RBD1016, a RNAi therapeutic, in Chinese subjects with chronic hepatitis B virus (HBV) infection
Journal of Hepatology·2023· 8 cited
Supplementary Table from Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model
2023Open Access
Data from Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model
2023Open Access
Data from Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model
2023Open Access
Supplementary Table from Kinetics of Senescence-associated Changes of Gene Expression in an Epithelial, Temperature-sensitive SV40 Large T Antigen Model
2023Open Access
Ionizable liposomal siRNA therapeutics enables potent and persistent treatment of Hepatitis B
Signal Transduction and Targeted Therapy·2022· 49 citedOpen Access
Core Role of Hydrophobic Core of Polymeric Nanomicelle in Endosomal Escape of siRNA
Nano Letters·2021· 95 cited
Harnessing pH-Sensitive Polycation Vehicles for the Efficient siRNA Delivery
ACS Applied Materials & Interfaces·2021· 36 cited
page 1 of 8Next →

Frequent Co-authors

Yuanyu Huang(23), Qiang Cheng(14), Quan Du(13), Huiqing Cao(13), Xing‐Jie Liang(12), Deyao Zhao(10), Shutao Guo(9), Liandong Deng(9), Tuo Wei(8), Anjie Dong(7), Xiaoxia Wang(7), Yidi Wu(7), Daoshu Lin(7), Shuquan Zheng(6), Jiang Qian(6), Lili Du(6), Anjie Dong(6), Jinfeng Xing(5), Ling Peng(5), Wendi Zhang(5)